Evidence map›Paper›PMID 41493064›Full record

ArticleJournal of chemical information and modeling2026

Toward In Situ Dynamics of DNA-Bound Full-Length p53 Tetramer.

Özlem Demir, Emilia P Barros, Rommie E Amaro

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Özlem DemirDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, San Diego, California 92093, United States.ORCID 0000-0002-3317-4731
Emilia P BarrosDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, San Diego, California 92093, United States.
Rommie E AmaroDepartment of Molecular Biology, University of California, La Jolla, San Diego, California 92093, United States.ORCID 0000-0002-9275-9553

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

p53 is the most important tumor suppressor in humans as well as the most frequently mutated gene found in human cancers, with ∼50% of all human tumors bearing p53 missense mutations that leave p53 inactive. Restoring p53 activity has been shown to lead to tumor regression even in advanced tumors in mouse models and thus is among the most attractive potential strategies for novel cancer therapy. Full-length p53 (fl-p53) consists of 393 residues and multiple domains, some of which are folded while others are disordered. Using the crystal structures of folded domains and integrative molecular modeling techniques for disordered domains, we generated the first wild-type (WT) fl-p53 tetramer model bound to DNA. When solvated, the system size was ∼500 K atoms, challenging extensive sampling. Using the Anton2 supercomputer for microsecond timescale simulations in explicit solvent and the rigorous Markov state model (MSM) framework, we elucidated the conformational landscape of wild-type p53 as well as two of the p53 hotspot cancer mutants, Y220C and G245S, in a physiological DNA-bound, full-length tetramer context. In the simulated timescale, DNA-bound fl-p53 tetramer bent DNA and formed a compact complex with interactions between the N-terminal and DNA-binding domains (DBDs) and C-terminal domains (CTDs) with DNA. The WT fl-p53 tetramer also sampled a unique quaternary DBD organization that is not accessed by the cancer mutants. The free energy landscapes indicated differential dynamics for the inner and outer p53 DBDs due to the dimer-dimer interface. The dynamics of the druggable L1/S3 pocket was also closely monitored. Ultimately, MSMs identified an underexplored loop 6 (L6) cryptic pocket and captured the effect of p53 tetramerization and cancer mutations.

Indexed as

DNAMolecular Dynamics SimulationProtein MultimerizationTumor Suppressor Protein p53HumansProtein BindingDNATumor Suppressor Protein p53

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.